Immunohistochemical studies on Waflp21, p16, pRb and p53 in human esophageal carcinomas and neighboring epithelia from a high-risk area in northern China

International Journal of Cancer

Volumn 72, Issue 5, 1997, Pages 746-751

  Yang, Guang Yu ^a   Zhang, Zhihua ^a   Liao, Jie ^a   Seril, Darren ^a   Wang, Li Dong ^a,b   Goldstein, Susan ^a   Yang, Chung S ^a  

^a RUTGERS UNIVERSITY   (United States)

^b ZHENGZHOU UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CELL CYCLE PROTEIN; CYCLINE; PROTEIN P16; PROTEIN P21; PROTEIN P53; RETINOBLASTOMA PROTEIN; CDKN1A PROTEIN, HUMAN; CYCLIN DEPENDENT KINASE INHIBITOR 1A; PROTEIN P16INK4A;

ARTICLE; CARCINOGENESIS; CELL CYCLE; CELL HYPERPLASIA; CONTROLLED STUDY; DYSPLASIA; ESOPHAGUS CARCINOMA; ESOPHAGUS MUCOSA; HUMAN; HUMAN TISSUE; PRIORITY JOURNAL; PROTEIN DETERMINATION; SQUAMOUS EPITHELIUM; TUMOR SUPPRESSOR GENE; CHINA; EPITHELIUM; ESOPHAGUS TUMOR; IMMUNOHISTOCHEMISTRY; METABOLISM; SQUAMOUS CELL CARCINOMA;

CARCINOMA, SQUAMOUS CELL; CHINA; CYCLIN-DEPENDENT KINASE INHIBITOR P16; CYCLIN-DEPENDENT KINASE INHIBITOR P21; CYCLINS; EPITHELIUM; ESOPHAGEAL NEOPLASMS; HUMANS; IMMUNOHISTOCHEMISTRY; RETINOBLASTOMA PROTEIN; TUMOR SUPPRESSOR PROTEIN P53;

EID: 0030610256     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0215(19970904)72:5<746::AID-IJC7>3.0.CO;2-S     Document Type: Article

References (23)

1. COPPOLLA, J.A., LEWIS, B.A. and COLE, M.D., Increased retinoblastoma gene expression is associated with late stages of differentiation in many different cell types. Oncogene, 5, 1731-1733 (1990).
2. CORDON-CARDO, C., Mutation of cell cycle regulators: biological and clinical implications for human neoplasia. Amer. J. Pathol., 147, 545-560 (1995).
3. DAWSEY, S.M., LEWIN, K.J., LIU, F.S., WANG, G.Q. and SHEN, Q., Esophageal morphology from Linxian, China: squamous histologic findings in 754 patients. Cancer, 73, 2027-2037 (1994).
4. FUCHS, E., Epidermal differentiation: the bare essentials. J. Cell Biol., 111, 2807-2814 (1990).
5. GAO, H., WANG, L.D., ZHOU, Q., HUANG, T.Y., HONG, J.Y., QIU, S.L. and YANG, C.S., p53 tumor suppressor gene mutation in early esophageal precancerous lesions and carcinoma among high risk populations in Henan, China. Cancer Res., 54, 4342-4346 (1994).
6. GREENBLATT, M.S., BENNETT, W.P., HOLLSTEIN, M. and HARRIS, C.C., Mutations in the p53 tumor suppressor gene: clues to cancer etiology and molecular pathogenesis. Cancer Res., 54, 4855-4878 (1994).
7. HALL, P.A., MCKEE, P.H., MENAGE, H.P., DOVER, R. and LANE, D.P., High levels of p53 protein in UV-irradiated normal human skin. Oncogene, 8, 203-207 (1993).
8. HARRIS, C.C., p53 tumor suppressor gene: from the basic research laboratory to clinic - an abridged historical perspective. Carcinogenesis, 17, 1187-1198 (1996).
9. HARTWELL, L.H., and KASTAN, M.B., Cell cycle control and cancer. Science, 266, 1821-1828 (1994).
10. KRANENBURG, O., VAN DER EB, A.J. and ZANTEMA, A., Cyclin-dependent kinases and pRb: regulators of the proliferation-differentiation switch. FEBS Lett., 367, 103-106 (1995).
11. INK4a expression in resected non-small cell lung tumors. Cancer Res., 56, 3415-3420 (1996).
12. ink4 requires functional retinoblastoma protein. Proc. nat. Acad. Sci. (Wash.), 92, 6289-6293 (1995).
13. Cip1 in muscle and other terminally differentiating cells. Science, 267, 1024-1027 (1995).
14. PESKO, P., RAKIC, S., MILICEVIC, M., BULAJIC, P. and GERZIC, Z., Prevalence and clinicopathologic features of multiple squamous cell carcinoma of the esophagus. Cancer, 73, 2687-2690 (1994).
15. PODUST, V.N., PODUST, L.M., GOUBIN, F., DUCOMMUN, B. and HUBSCHER, U., Mechanism of inhibition of proliferating cell nuclear antigen-dependent DNA synthesis by the cyclin-dependent kinase inhibitor p21. Biochemistry, 34, 8869-8875 (1995).
16. REED, A.L., CALIFANO, J., CAIRNS, P., WESTRA, W.H., JONES, R.M., KOCH, W., AHRENDT, S., EBY, Y. SEWELL, D., NAWROZ, H., BARTEK, J. and SIDRANSKY, D., High frequency of p16 (CDKN2/MTS-1/INK4A) inactivation in head and neck squamous cell carcinoma. Cancer Res., 56, 3630-3633 (1996).
17. SAKAGUCHI, M., FUJII, Y., HIRABAYASHI, H., YOON, H.-E., KOMOTO, Y., OUE, T., KUSAFUKA, T., OKADA, A. and MATSUDA, H., Inversely correlated expression of p16 and Rb protein in non-small cell lung cancers: an immunohistochemical study. Int. J. Cancer, 65, 442-445 (1996).
18. SHERR, C.J., Cancer cell cycles. Science, 274, 1672-1677 (1996).
19. SLAUGHTER, D.P., SOUTHWICK, H.W. and SMEJKAL, W., "Field cancerization" in oral stratified squamous epithelium. Cancer, 6, 963-968 (1953).
20. WANG, L.D., HONG, J.Y., QIU, S.L., GAO, H. and YANG, C.S., Accumulation of p53 protein in human esophageal precancerous lesions: a possible early biomarker for carcinogenesis. Cancer Res., 53, 1783-1787 (1993).
21. WANG, L.D., SHI, S.T., ZHOU, Q., GOLDSTEIN, S., HONG, J.Y., SHAO, P., QIU, S.L. and YANG, C.S., Changes in p53 and cyclin D1 protein levels and cell proliferation in different stages of human esophageal and gastric cardia carcinogenesis. Int. J. Cancer, 59, 514-519 (1994).
22. WANG, L.D., ZHOU, Q., HONG, J.-Y., QIU, S.-L. and YANG, C.S., p53 protein accumulation and gene mutations in multifocal esophageal precancerous lesions from symptom free subjects in a high incidence area for esophageal carcinoma in Henan, China. Cancer, 77, 1244-1249 (1996).
23. YANG, C.S., Research on esophageal cancer in China, a review. Cancer Res., 40, 2633-2644 (1980).